The European Commission has approved our medicine for adults living with uncontrolled chronic obstructive pulmonary disease (#COPD), a respiratory disease that leads to exacerbations and causes progressive lung function decline and impaired quality of life. For a community that has not seen a new treatment approach in more than a decade, this marks an important step forward for those living with the disease in the EU. Read more about the news: https://bit.ly/3RPlLTW Sanofi
Congrats! important goal achieved
Fantastic news for the COPD community in the EU! This approval marks a significant advancement in treatment options after a decade.
Congrats
Congratulations on bench to bedside translation
Fantastic
Amazing treatment for COPD
Great news for patients!
Awesome new for COPD patients! 😍
Congrats! important goal achieved